Emmune Revenue and Competitors

Jupiter, FL

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Emmune's estimated annual revenue is currently $775k per year.(i)
  • Emmune's estimated revenue per employee is $155,000

Employee Data

  • Emmune has 5 Employees.(i)
  • Emmune grew their employee count by -29% last year.

Emmune's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
Accounting and Operating DirectorReveal Email/Phone
3
Director In Vivo PharmacologyReveal Email/Phone
4
Research ScientistReveal Email/Phone
5
Assistant ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is Emmune?

Emmune, Inc. is a start-up biotechnology company that has a novel approach for treating and preventing HIV infection. We engineered a synthetic antibody from the receptors that HIV uses to infect T cells, CD4 and CCR5. Because this synthetic antibody, known as “eCD4-Ig,” is built from the viral receptor and co-receptor, it recognizes 100% of HIV-1 isolates. A single intramuscular inoculation with an AAV vector expressing eCD4-Ig protected monkeys from multiple intravenous challenges with live virus.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M525%N/A
#2
$0.4M5-17%N/A
#3
$0.8M5-29%N/A
#4
$0.4M6100%N/A
#5
$0.9M6-45%N/A